1. Multidrug resistance profile in Lactobacillus delbrueckii: a food industry species with probiotic properties.
- Author
-
Quaresma LS, Santos RCV, Gomes GC, Américo MF, Campos GM, Laguna JG, Barroso FAL, Azevedo V, and de Jesus LCL
- Subjects
- Drug Resistance, Multiple, Bacterial genetics, Food Industry, Food Microbiology, Fermented Foods microbiology, Probiotics pharmacology, Lactobacillus delbrueckii genetics, Lactobacillus delbrueckii drug effects, Anti-Bacterial Agents pharmacology
- Abstract
Lactobacillus delbrueckii, a widely used lactic acid bacterium in the food industry, has been studied for its probiotic properties and reservoir of antibiotic-resistant genes, raising safety concerns for probiotic formulations and fermented products. This review consolidates findings from 60 articles published between 2012 and 2023, focusing on the global antibiotic resistance profile and associated genetic factors in L. delbrueckii strains. Resistance to aminoglycosides, particularly streptomycin, kanamycin, and gentamicin, as well as resistance to glycopeptides (vancomycin), fluoroquinolones (ciprofloxacin), and tetracyclines was predominant. Notably, although resistance genes have been identified, they have not been linked to mobile genetic elements, reducing the risk of dissemination. However, a significant limitation is the insufficient exploration of responsible genes or mobile elements in 80% of studies, hindering safety assessments. Additionally, most articles originated from Asian and Middle Eastern countries, with strains often isolated from fermented dairy foods. Therefore, these findings underscore the necessity for comprehensive analyses of new strains of L. delbrueckii for potential industrial and biotherapeutic applications and in combating the rise of antibiotic-resistant pathogens., (© 2024. The Author(s), under exclusive licence to Springer Nature B.V.)
- Published
- 2024
- Full Text
- View/download PDF